Guangxi Liuzhou Pharm Co Ltd (603368) — Cash Flow-to-Debt Ratio
Guangxi Liuzhou Pharm Co Ltd (603368) has a Cash Flow-to-Debt Ratio of 0.00x as of September 2025, meaning its operating cash flow of CN¥45.64 Million could theoretically repay 0% of its total liabilities (CN¥13.05 Billion) in one year. See 603368 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Guangxi Liuzhou Pharm Co Ltd Cash Flow-to-Debt Ratio (2011–2024)
Historical debt coverage capacity for Guangxi Liuzhou Pharm Co Ltd across 14 annual periods. Also explore 603368 net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Guangxi Liuzhou Pharm Co Ltd (2011–2024)
Year-by-year debt coverage analysis for Guangxi Liuzhou Pharm Co Ltd. For market capitalisation and broader financial context, see Guangxi Liuzhou Pharm Co Ltd stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.06x | CN¥838.51 Million | CN¥13.33 Billion | ▲ +38.6% |
| 2023 | 0.05x | CN¥594.41 Million | CN¥13.10 Billion | ▲ +9.7% |
| 2022 | 0.04x | CN¥506.43 Million | CN¥12.24 Billion | ▲ +25.1% |
| 2021 | 0.03x | CN¥332.88 Million | CN¥10.07 Billion | ▼ -53.4% |
| 2020 | 0.07x | CN¥664.69 Million | CN¥9.36 Billion | ▲ +25.5% |
| 2019 | 0.06x | CN¥412.91 Million | CN¥7.30 Billion | ▲ +1352.1% |
| 2018 | 0.00x | CN¥22.30 Million | CN¥5.73 Billion | ▲ +104.7% |
| 2017 | -0.08x | CN¥-332.59 Million | CN¥3.99 Billion | ▼ -334.2% |
| 2016 | 0.04x | CN¥108.39 Million | CN¥3.04 Billion | ▲ +197.8% |
| 2015 | -0.04x | CN¥-107.25 Million | CN¥2.94 Billion | ▲ +29.5% |
| 2014 | -0.05x | CN¥-132.42 Million | CN¥2.56 Billion | ▼ -608.6% |
| 2013 | 0.01x | CN¥22.33 Million | CN¥2.20 Billion | ▼ -72.3% |
| 2012 | 0.04x | CN¥60.51 Million | CN¥1.65 Billion | ▼ -64.3% |
| 2011 | 0.10x | CN¥133.38 Million | CN¥1.30 Billion | — |